Form 4: Dentsply Sirona Director Acquires Phantom Stock Under Deferred Compensation Plan

Jonathan Jay Mazelsky, a director at Dentsply Sirona, acquired phantom stock equivalent to 935.7631 shares of common stock on September 30, 2024, under the directors' deferred compensation plan.

Summary

• On September 30, 2024, Jonathan Jay Mazelsky, a director of Dentsply Sirona Inc. (XRAY), acquired 935.7631 shares of phantom stock.
• This acquisition was made under the Directors' Deferred Compensation (DDC) plan.
• Each share of phantom stock is economically equivalent to one share of Dentsply Sirona common stock.
• The phantom stock becomes payable in common stock upon the director's termination of service.
• Following the transaction, Mazelsky beneficially owns 4,433.7381 shares of phantom stock.
• The price of the derivative security is $25.13.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation, which is generally neutral. The acquisition of phantom stock can be seen as a positive sign of alignment between the director and the company's long-term performance.

Positives

• The acquisition of phantom stock aligns the director's interests with the long-term performance of the company.
• The deferred compensation plan allows directors to accumulate company stock over time.

Future Outlook

The phantom stock will be converted to common stock upon the director's termination of service.

Industry Context

This filing is a routine disclosure related to executive compensation and is common among publicly traded companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates